Your browser doesn't support javascript.
loading
An update on the role of complement in hepatocellular carcinoma.
Xiao, Zhijie; Yeung, Charlie Lot Sum; Yam, Judy Wai Ping; Mao, Xiaowen.
Affiliation
  • Xiao Z; Scientific Research Centre, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
  • Yeung CLS; Department of Pathology, School of Clinical Medicine, Faculty of Medicine, the University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Yam JWP; Department of Pathology, School of Clinical Medicine, Faculty of Medicine, the University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Mao X; Department of Pathology, School of Clinical Medicine, Faculty of Medicine, the University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Front Immunol ; 13: 1007382, 2022.
Article in En | MEDLINE | ID: mdl-36341431
ABSTRACT
As a main producer of complement, the environment in the liver is greatly affected by the complement system. Although the complement system is considered to have the ability of nonself discrimination, remarkable studies have revealed the tight association between improper complement activation in tumour initiation and progression. As complement activation predominantly occurs within the liver, the protumourigenic role of the complement system may contribute to the development of hepatocellular carcinoma (HCC). Improvement in the understanding of the molecular targets involved in complement-mediated tumour development, metastasis, and tumour-promoting inflammation in HCC would certainly aid in the development of better treatments. This minireview is focused on recent findings of the protumourigenic role of the complement system in HCC.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: China